[Intralipid infusion in familial hypercholesterolemia].

Area of Science:

• Cardiovascular Science
• Lipid Metabolism

Context:

• Familial hypercholesterolemia (FH) is a severe genetic disorder.
• Atherosclerosis is a major cardiovascular disease.
• Intralipid, a lipid emulsion, has shown potential in animal models.

Purpose:

• To investigate the anti-atherogenic effects of Intralipid in humans.
• To assess Intralipid's impact on cholesterol metabolism and platelet aggregation.

Summary:

• Intravenous Intralipid infusions were administered to FH patients and controls.
• Serum from infusions inhibited intracellular cholesterol esterification in macrophages.
• Platelet aggregation significantly decreased post-infusion, persisting for 18 hours.

Impact:

• Intralipid infusion demonstrates potential anti-atherogenic properties.
• This suggests a novel therapeutic approach for severe atherosclerosis.
• Further investigation in patients with severe atherosclerosis is warranted.